TABLE 4.
MALDI-TOF MS results in relation to the original clinical diagnostic request
| Virus analysis requested (no. of samples) | No. of samples determined to be positive by MALDI-TOF MS analysis for:
|
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSV-1 | HSV-2 | CMV | VZV | EBVA | EBVB | HHV8 | HHV6 | HHV7 | Two HHVsa | Three HHVsa | Four HHVsa | |
| HSV (435) | 100 | 107 | 0 | 20b | 11 | 1 | 0 | 5 | 21 | 16c | 1d | 1e |
| CMV (129) | 0 | 0 | 56 | 0 | 4 | 1 | 0 | 2 | 3 | 6f | ||
| VZV (164) | 14 | 16g | 0 | 77 | 0 | 0 | 0 | 4 | 0 | 5h | ||
| EBV (164) | 0 | 0 | 0 | 0 | 56 | 2 | 0 | 2 | 0 | 1i | ||
| HHV8j (22) | 0 | 0 | 1 | 0 | 1 | 0 | 9 | 0 | 0 | 2k | ||
Either two, three, or four herpesviruses, as indicated in the respective footnotes, were detected in the same samples; these values were also included in the column for respective virus.
Fourteen samples were also submitted for VZV analysis.
Three EBVA and HHV7, one VZV and HHV6, two EBVA and HSV-1, one EBVA and HSV-2, one HSV-1 and HSV-2, two HHV6 and HSV-1, and six HHV7 and HSV-1.
HSV-1, HHV6, and HHV7.
EBVA, EBVB, HSV-1, and HHV7.
Two EBVA and CMV, one EBVB and CMV, one HHV6 and CMV, one HSV-1 and CMV, and one HHV7 and CMV.
Three samples also submitted for HSV analysis.
Three HSV-1 and HHV6, one HHV6 and VZV, one HSV-1 and VZV, and one EBV and HHV7.
EBV and HHV6.
Not clinically diagnosed
One HHV8 and CMV and one HHV8 and EBVA.